Effects of Extended Release Niacin added to Simvastatin/Ezetemibe on Glucose and Insulin values in AIM HIGH

BACKGROUND: Niacin is an anti-dyslipidemic agent that may cause blood sugar elevation in patients with diabetes, but its effects on glucose and insulin values in non-diabetic statin-treated subjects with cardiovascular disease and at high risk for diabetes are less well known. METHODS: This was a pr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Med
Main Authors: Goldberg, Ronald B., Bittner, Vera A., Dunbar, Richard L., Fleg, Jerome L., Grunberger, George, Guyton, John R., Leiter, Lawrence A., McBride, Ruth, Robinson, Jennifer G., Simmons, Debra L., Wysham, Carol, Xu, Ping, Boden, William E.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914402/
https://ncbi.nlm.nih.gov/pubmed/27036394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2016.02.039
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki